Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Clinical trial NCT01804530 · TERMINATED

Trial details

NCT number: NCT01804530
Sponsor: Plexxikon
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations Tenosynovial Giant Cell Tumor

Start date: 2013-08-01
Primary completion: 2018-01-24
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.